mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.067 |
0.06 |
mRNA |
narciclasine |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.06 |
mRNA |
AZD0530 |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.07 |
mRNA |
cimetidine |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.07 |
mRNA |
BIBW2992 |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.07 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.07 |
mRNA |
alvocidib |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.07 |
mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.08 |
mRNA |
FK866 |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.08 |
mRNA |
Repligen 136 |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.08 |